Searched for
MERCK PHARMA
India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...- Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata MotorsIndian markets saw volatility and closed lower on Wednesday. Key companies are in focus due to significant developments. SoftBank reduced i...
- Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facilityAurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines f...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Sun Pharma to buy Organon in $11.75 billion all-cash dealSun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion,...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Merck braces for Keytruda patent loss with $6.7 billion Terns betMerck is acquiring Terns Pharma for $6.7 billion to strengthen its cancer drug pipeline, aiming to reduce reliance on its blockbuster Keytr...
- Verona Pharma stock jumps 20% on $10B Merck deal—can FDA-approved Ohtuvayre reshape COPD care?Verona Pharma stock jumped 20% after Merck announced it will acquire the British biotech in a $10 billion deal. Merck will pay $107 per sha...
- Merck merges pharma, consumer health units; aims to ramp up businessesGoing against the grain: With the unique hybrid model for India, co aims at building scale & ramping up businesses.
- Sun Pharmaceutical, Merck & Co call off 2011 JV: SourcesSun Pharma & US-based Merck & Co have called off their more than three-year-old joint venture that aimed to bring innovative drugs to emerg...
- Sun Pharma, Merck & Co Inc enter into pact for TildrakizumabUnder terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck.
- Merck, Sun Pharma ink JV to bring innovative drugs to EMsSun Pharmaceutical will bring its product development skills to the table, while Merck will help with market presence.
- Merck scouts for marketing, licensing pacts with Indian cosMerck & Co, is looking at in-licensing and co-marketing arrangements with Indian pharma cos as it wants to realise its ambitions to become ...
- Dishman Pharma likely to get $40 mn from Abbott & MerckAccording to sources, the company officials met Abbott & Merck last week. Abbott & Merck are expected to come for plant inspection next mon...
- Merck buys Schering-Plough in $41.1b cash-&-stock dealUS-based Merck & Co is acquiring Schering-Plough for $41.1 billion in a cash-and-stock deal, to create a $47 billion drug major.
- Cos exit generics for core focusAs international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
- Milestone for GlenmarkGlenmark’s out-licensing deal with the German pharma major, Merck KGaA, for its diabetes molecule, a DPP-IV inhibitor, is an important mile...
- Merck inks pact to develop, sell Glenmark diabetes drugGerman pharma major Merck KGaA and Glenmark Pharmaceuticals SA (Switzerland), a wholly-owned subsidiary of Glenmark Pharma India, announced...
Load More
